Humacyte, Inc.
HUMA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $45 | $80 | $150 | $218 |
| Short-Term Investments | $0 | $0 | $2 | $8 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $3 | $2 | $4 |
| Total Curr. Assets | $48 | $83 | $154 | $229 |
| Property Plant & Equip (Net) | $39 | $44 | $50 | $57 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $51 | $1 | $0 | $0 |
| Total NC Assets | $90 | $45 | $50 | $57 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $138 | $128 | $204 | $287 |
| Liabilities | – | – | – | – |
| Payables | $4 | $6 | $2 | $2 |
| Short-Term Debt | $3 | $3 | $11 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $13 | $9 | $7 | $7 |
| Total Curr. Liab. | $20 | $18 | $20 | $11 |
| LT Debt | $14 | $55 | $39 | $49 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $157 | $41 | $29 | $104 |
| Total NC Liab. | $171 | $96 | $68 | $153 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $17 | $19 | $21 | $24 |
| Total Liabilities | $191 | $115 | $87 | $164 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$686 | -$537 | -$427 | -$415 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $633 | $551 | $543 | $537 |
| Total Equity | -$53 | $14 | $117 | $122 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $138 | $128 | $204 | $287 |
| Net Debt | -$28 | -$23 | -$100 | -$166 |